On the road to replacing invasive testing with cell‐based NIPT: Five clinical cases with aneuploidies, microduplication, unbalanced structural rearrangement, or mosaicism

Objective:

Trophoblastic fetal cells harvested from maternal blood have the capacity to be
used for copy number analyses in a cell‐based non‐invasive prenatal test (cbNIPT). Potentially, this
will result in increased resolution for detection of subchromosomal aberrations due to high quality
DNA not intermixed with maternal DNA. We present 5 selected clinical cases from first trimester
pregnancies where cbNIPT was used to demonstrate a wide range of clinically relevant aberrations.

Method:

Blood samples were collected from high risk pregnancies in gestational week 12 + 1
to 12 + 5. Fetal trophoblast cells were enriched and stained using fetal cell specific antibodies.
The enriched cell fraction was scanned, and fetal cells were picked using a capillary‐based cell
picking instrument. Subsequently, whole genome amplification (WGA) was performed on fetal
cells, and the DNA was analyzed blindly by array comparative genomic hybridization (aCGH).

Results:

We present 5 cases where non‐invasive cell‐based prenatal test results are compared
with aCGH results on chorionic villus samples (CVS), demonstrating aneuploidies including mosaicism, unbalanced translocations, subchromosomal deletions, or duplications.

Conclusion:

Aneuploidy and subchromosomal aberrations can be detected using fetal cells
harvested from maternal blood. The method has the future potential of being offered as a cell based NIPT with large high genomic resolution.

READ MORE